P304A real-world comparison of vernakalant efficacy and safety for pharmacological cardioversion in patients with recent-onset atrial fibrillation in an emergency department and after cardiac surgery

  • J. Osca Asensi, MJ. Ferre, MJ. Perez-Dura, R. Vicente, P. Alonso, O. Cano, A. Andres, MJ. Sancho Tello, J. Olague, L. Martinez-Dolz
  • EP Europace, June 2017, Oxford University Press (OUP)
  • DOI: 10.1093/ehjci/eux141.031

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1093/ehjci/eux141.031